BAROSTIM NEO® System
BAROSTIM NEO® System is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Baroreflex Activation Therapy for Heart Failure
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
BAROSTIM THERAPY™ In Resistant Hypertension
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction
Clinical Trials (8)
Baroreflex Activation Therapy for Heart Failure
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
BAROSTIM THERAPY™ In Resistant Hypertension
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction
Baroreflex Activation Therapy in Heart Failure
BAROSTIM NEO System in the Treatment of Heart Failure
BAROSTIM® Hope for Heart Failure Study
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8